Eddy covariance

PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform

Retrieved on: 
Monday, December 4, 2023
Manufacturing, Other Health, Environment, Other Science, Pharmaceutical, Research, Other Technology, Sustainability, Medical Devices, Hardware, Science, Technology, Medical Supplies, General Health, Agriculture, Natural Resources, Health, Health Technology, Chemicals, Plastics, Massive parallel sequencing, Safety, DNA, Laboratory, Food, Genomics, Medicine, Data analysis, PerkinElmer, DNA fragmentation, Drug discovery, Growth, NGS, Fine chemical, Renewable energy, Eddy covariance

The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market.

Key Points: 
  • The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market.
  • Covaris’ solutions empower customers to accelerate the pace of research and drug discovery for clinical diagnostics, biopharma, and research markets globally.
  • We see significant growth opportunities resulting from the combined resources of both companies, with PerkinElmer’s global scale unlocking commercial opportunities for Covaris,” said Dirk Bontridder, CEO of PerkinElmer.
  • Covaris will now have access to PerkinElmer’s global reach, technical and operating capabilities to continue its rapid growth trajectory.

World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Symposium

Retrieved on: 
Wednesday, September 20, 2023
Genotype, Scripps Research, Cell biology, University of California, Berkeley, Consortium, Exhibition, Harvard University, Proteoform, Abraxis BioScience, Life, Single-cell analysis, Proteomics, Medicine, Research, Thermo Fisher Scientific, Genomics, Harvard Medical School, Agilent Technologies, Chan Zuckerberg Biohub, UC, Symposium, Wyss Institute, Seer, Biological engineering, Poster, Phenotype, Pharmaceutical industry, Bruker, Eddy covariance

CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- The 2nd International Top-Down Proteomics Symposium will bring together world leaders in the fields of proteomics, proteoform biology, cell biology, and genomics to present their latest research findings as well as to discuss future directions for building the bridge from genotype to phenotype. The Symposium is hosted by the Consortium for Top-Down Proteomics together with Northwestern University’s Chemistry of Life Processes Institute and will be held in Chicago, IL October 3-5, 2023.

Key Points: 
  • The Symposium will be held Oct. 3-5, 2023 in Chicago, IL.
  • CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- The 2nd International Top-Down Proteomics Symposium will bring together world leaders in the fields of proteomics, proteoform biology, cell biology, and genomics to present their latest research findings as well as to discuss future directions for building the bridge from genotype to phenotype.
  • The Symposium is hosted by the Consortium for Top-Down Proteomics together with Northwestern University’s Chemistry of Life Processes Institute and will be held in Chicago, IL October 3-5, 2023.
  • The Symposium is generously supported by sponsorships from Bruker, Quantum-Si, Sciex, Thermo Fisher Scientific, Nautilus Biotechnology, Glyphic Biotechnologies, PacBio, Seer, Agilent, ZefSci, Covaris, CMP Scientific, and Affinisep.

Comprehensive and Reliable Total Nucleic Acid Extraction from FFPE Samples with Covaris truXTRAC® FFPE SMART Solutions

Retrieved on: 
Monday, April 17, 2023
Research, Genetics, Clinical Trials, Health Technology, Biotechnology, Health, Pharmaceutical, Other Science, Science, Tissue, DNA, AFA, Workflow, Hexadecane, RNA, Laboratory, Fine chemical, Eddy covariance

Covaris, LLC, a leader in pre-analytical sample preparation technologies, proudly unveils a comprehensive, fully automatable deparaffinization and total nucleic acid extraction workflow for formalin-fixed paraffin-embedded (FFPE) samples.

Key Points: 
  • Covaris, LLC, a leader in pre-analytical sample preparation technologies, proudly unveils a comprehensive, fully automatable deparaffinization and total nucleic acid extraction workflow for formalin-fixed paraffin-embedded (FFPE) samples.
  • Covaris truXTRAC FFPE SMART Solutions ensure extraction and purification of DNA as well as RNA, which is otherwise difficult to process from FFPE samples.
  • Compared to traditional workflows for FFPE samples, truXTRAC FFPE SMART Solutions do not require use of any harmful organic solvents such as xylene or hexadecane.
  • “Covaris’ truXTRAC FFPE SMART Solutions ensure high quality and yield of DNA and RNA while addressing a wide range of throughput requirements.

Covaris Appoints Annemarie Watson as Chief Executive Officer

Retrieved on: 
Monday, August 1, 2022
Other Manufacturing, Research, Finance, Genetics, Professional Services, Manufacturing, Biotechnology, Health, Science, Harvard Business School, DNA, Ortho Clinical Diagnostics, Radiopharmaceutical, Laboratory, Industry, Boston Consulting Group, Culture, Research, DNA fragmentation, New Mountain, Honda, CTO, Crane Currency, Leadership, Technology, MBA, Senior, Senior advisor, Honda of Canada Manufacturing, Boston, New Mountain Capital, LLC, Eurofins Scientific, Growth, MDS, Mathematics, Mass spectrometry, Management, Eddy covariance, Engineering, Director, Nordion

Covaris, LLC (Covaris or the Company), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately.

Key Points: 
  • Covaris, LLC (Covaris or the Company), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately.
  • Ms. Watson succeeds Covaris founder Jim Laugharn, who will remain an investor in Covaris and on serve on the Companys Board of Directors, as well as assuming the role of Chief Technology Officer.
  • We look forward to working with Annemarie as we leverage Covaris leading biomolecule extraction technology to accelerate life sciences innovation.
  • I am grateful to have been given the opportunity to lead Covaris, a leader in the life sciences industry with a strong culture of innovation, said Annemarie Watson, Chief Executive Officer of Covaris.